| __timestamp | Corcept Therapeutics Incorporated | Telix Pharmaceuticals Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 882000 | 22622695 |
| Thursday, January 1, 2015 | 1361000 | 24863028 |
| Friday, January 1, 2016 | 2058000 | 21351001 |
| Sunday, January 1, 2017 | 3554000 | 53837297 |
| Monday, January 1, 2018 | 5215000 | 16080096 |
| Tuesday, January 1, 2019 | 5504000 | 18525736 |
| Wednesday, January 1, 2020 | 5582000 | 2024000 |
| Friday, January 1, 2021 | 5281000 | 2548000 |
| Saturday, January 1, 2022 | 5385000 | 61556000 |
| Sunday, January 1, 2023 | 6481000 | 188157000 |
Unleashing the power of data
In the ever-evolving pharmaceutical industry, understanding cost structures is crucial for investors and stakeholders. This analysis delves into the cost of revenue trends for Corcept Therapeutics Incorporated and Telix Pharmaceuticals Limited from 2014 to 2023. Over this period, Corcept Therapeutics saw a steady increase in its cost of revenue, peaking at approximately $6.5 million in 2023, marking a growth of over 630% from 2014. Meanwhile, Telix Pharmaceuticals experienced a more volatile trajectory, with a dramatic surge in 2023, reaching nearly $188 million, a staggering increase of over 730% from its 2014 figures. This stark contrast highlights the differing operational scales and market strategies of these two companies. Investors should note the significant growth in Telix's cost of revenue, which may indicate aggressive expansion or increased production costs.
Cost of Revenue Comparison: Eli Lilly and Company vs Corcept Therapeutics Incorporated
Analyzing Cost of Revenue: Novo Nordisk A/S and Corcept Therapeutics Incorporated
Analyzing Cost of Revenue: Merck & Co., Inc. and Corcept Therapeutics Incorporated
Cost of Revenue: Key Insights for Takeda Pharmaceutical Company Limited and Corcept Therapeutics Incorporated
Cost of Revenue Comparison: Biogen Inc. vs Corcept Therapeutics Incorporated
Cost of Revenue: Key Insights for Dr. Reddy's Laboratories Limited and Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated vs Supernus Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Telix Pharmaceuticals Limited and Amneal Pharmaceuticals, Inc.'s Expenses
Cost Insights: Breaking Down Telix Pharmaceuticals Limited and Ionis Pharmaceuticals, Inc.'s Expenses
Cost of Revenue Comparison: Telix Pharmaceuticals Limited vs Xenon Pharmaceuticals Inc.
Analyzing Cost of Revenue: Telix Pharmaceuticals Limited and Vericel Corporation
Cost of Revenue: Key Insights for Telix Pharmaceuticals Limited and Wave Life Sciences Ltd.